BACCI: A phase II randomized, double-blind, placebo-controlled study of capecitabine bevacizumab plus atezolizumab versus capecitabine bevacizumab plus placebo in patients with refractory metastatic colorectal cancer.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Mettu, NB; Niedzwiecki, D; Boland, PM; Fakih, M; Arrowood, C; Bolch, E; Hurwitz, H; Grothey, A

Published Date

  • February 2018

Published In

Volume / Issue

  • 36 / 4_suppl

Start / End Page

  • TPS873 - TPS873

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.4_suppl.tps873